Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JELU-Werk is a family-owned German company that specializes in the production of high-quality natural fibers from renewable raw materials. The company is a key supplier to the pharmaceutical, food, and technical industries, offering specialized products like cellulose and microcrystalline cellulose (MCC) under the brand name JELUCEL. In the life sciences sector, these products serve as essential excipients for tablet manufacturing, acting as binders, fillers, and disintegrants. JELU-Werk operates with a strong focus on sustainability and quality, maintaining certifications such as ISO 9001 and HACCP. Their manufacturing facility in Rosenberg, Germany, processes tens of thousands of tons of raw material annually to serve a global customer base. The company's expertise in fiber technology allows it to provide functional additives that improve the texture, stability, and performance of various end products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JELU-Werk.